Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap56.06M
Market cap56.06M
Price-Earnings ratio-1.03
Price-Earnings ratio-1.03
Dividend yield—
Dividend yield—
Average volume200.46K
Average volume200.46K
High today$0.3939
High today$0.3939
Low today$0.3501
Low today$0.3501
Open price$0.3644
Open price$0.3644
Volume144.66K
Volume144.66K
52 Week high$3.53
52 Week high$3.53
52 Week low$0.2928
52 Week low$0.2928
IMMP News
TipRanks 5d
Immutep balances TACTI-004 setback with upbeat efti and IMP761 dataUnlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.